http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-202006015207-U1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c58a89c3439adb624ee177b38988f98 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-49 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 2006-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-202006015207-U1 |
| titleOfInvention | Use of plasminogen activators for the treatment of venous thromboembolism |
| abstract | usena plasminogen activator for the manufacture of a medicament fornTreatment of venous thromboembolism, wherein the plasminogen activatornin comparison with the activitynwithout fibrin at least a 550-fold increased activity in the presence of fibrinnhaving. |
| priorityDate | 2006-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.